FDA Inspection 816790 — Meiji Seika Pharma Co., Ltd.
The FDA completed an inspection of Meiji Seika Pharma Co., Ltd. on Dec 14, 2012 in Kitakami. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Dec 14, 2012
- Fiscal Year
- 2013
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Kitakami (Japan)